Addiction Recovery Research Center, Fralin Biomedical Research Institute at VTC, Roanoke, VA, United States.
Department of Psychology, Arizona State University, Tempe, AZ, United States.
Drug Alcohol Depend. 2021 Aug 1;225:108795. doi: 10.1016/j.drugalcdep.2021.108795. Epub 2021 Jun 6.
The Experimental Medicine Approach offers a unique perspective to determine clinical behavior change by engaging a target underlying the cause of a disorder. The present work engaged a novel target of addiction, Reinforcer Pathology, in two studies to test changes in behavior among individuals with cocaine use disorder.
In Study 1, n = 44 participants engaged the temporal window with episodic future thinking (EFT), a positive prospection exercise. Changes in temporal view and cocaine valuation were tested using delay discounting and behavioral economic demand, respectively. Additionally, a computational model assessed the relative reliance on the near- and far-sighted systems during EFT. In Study 2, n = 71 engaged the temporal window with a negatively-valenced hurricane scenario to test the opposite effects on window length and cocaine valuation.
Results demonstrated systematic and symmetrical engagement of the behavioral target. Study 1 robustly replicated previous work, wherein EFT lengthened the temporal window and decreased cocaine valuation. Moreover, EFT increased the weighting of the modeled far-sighted system, increasing the relative impact of long-term discounting decisions. Study 2 produced opposite outcomes, shortened temporal window and increased cocaine valuation.
This approximately equal and opposite reaction to the manipulations supports reinforcer pathology theory and implicates the temporal window over which rewards are valued as a target to be pushed and pulled to produce clinically meaningful behavior change. Using the Experimental Medicine Approach as a guide, future work should identify new potential interventions to engage reinforcer pathology and use the clinically relevant outcomes as a litmus test for mechanism.
实验医学方法通过关注疾病原因背后的目标,提供了一种独特的视角来确定临床行为的变化。本研究采用了一种新的成瘾靶点——强化物病理学,在两项研究中测试了可卡因使用障碍个体行为的变化。
在研究 1 中,n=44 名参与者参与了时间窗口的情节性未来思考(EFT),这是一种积极的前瞻性练习。使用延迟折扣和行为经济学需求分别测试了时间观和可卡因估值的变化。此外,计算模型评估了 EFT 期间近远景系统的相对依赖程度。在研究 2 中,n=71 名参与者参与了带有负面情绪的飓风情景的时间窗口,以测试对窗口长度和可卡因估值的相反影响。
结果表明行为目标的系统和对称参与。研究 1 有力地复制了先前的工作,其中 EFT 延长了时间窗口并降低了可卡因估值。此外,EFT 增加了模型中远景系统的权重,增加了长期折扣决策的相对影响。研究 2 产生了相反的结果,缩短了时间窗口并增加了可卡因估值。
这种对操纵的大致相等和相反的反应支持了强化物病理学理论,并暗示了作为目标的奖励价值的时间窗口可以被推动和拉动,以产生具有临床意义的行为变化。未来的工作应该以实验医学方法为指导,确定新的潜在干预措施来参与强化物病理学,并将临床相关的结果作为机制的试金石。